BioSpace1mon
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
BRAFTOVI in combination with cetuximab and mFOLFOX6 is the first and only combination regimen with targeted therapy approved for use as early as first-line for patients with metastatic colorectal ...
Farmers Weekly1mon
One-pass Katara combination drill added to Bednar line-up
The already comprehensive seed drill portfolio developed by Czech manufacturer Bednar is being further expanded with a new one-pass drilling combination. Based on the company’s Kator KN rotary ...